Estrogen Receptor α mRNA important than E2 Is an Independent biomarker for Postmenopausal Osteoporosis
博士 === 中山醫學大學 === 醫學研究所 === 103 === Objective:Up- and down-regulation of the osteoclastogenesis response depends on the Estrogen/estrogen receptor (ER) signaling pathway. Previous reports have shown that promoter hypermethylation and gene polymorphism of ER α are risks for menopausal osteoporosis. N...
Main Authors: | Chi-Wen Chou, 周啟文 |
---|---|
Other Authors: | Chung-Hung Tsai |
Format: | Others |
Language: | zh-TW |
Published: |
2015
|
Online Access: | http://ndltd.ncl.edu.tw/handle/60012496909641838564 |
Similar Items
-
Estrogenic receptors a and p gene polymorphisms in postmenopausal osteoporosis
by: K A Maslova, et al.
Published: (2008-06-01) -
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
by: Luigi Gennari, et al.
Published: (2010-01-01) -
Importance of Biochemical Markers in Postmenopausal and Senile Osteoporosis
by: Deniz Evcik, et al.
Published: (2002-12-01) -
Construction of an miRNA-Regulated Pathway Network Reveals Candidate Biomarkers for Postmenopausal Osteoporosis
by: Min Shao
Published: (2017-01-01) -
Adiponectin as a Biomarker of Osteoporosis in Postmenopausal Women: Controversies
by: Anna Lubkowska, et al.
Published: (2014-01-01)